SMS Lifesciences India Limited (SMSLIFE.NS)

INR 1133.7

(1.45%)

Operating Expenses Summary of SMS Lifesciences India Limited

SMS Lifesciences India Limited's latest annual operating expenses in 2023 was 602.96 Million INR , down -75.89% from previous year.
SMS Lifesciences India Limited's latest quarterly operating expenses in 2024 Q1 was 22.31 Million INR , up 148.8% from previous quarter.
SMS Lifesciences India Limited reported a annual operating expenses of 695.93 Million INR in annual operating expenses 2022, up 10.09% from previous year.
SMS Lifesciences India Limited reported a annual operating expenses of 632.15 Million INR in annual operating expenses 2021, up 32.17% from previous year.
SMS Lifesciences India Limited reported a quarterly operating expenses of 40.78 Million INR for 2023 Q3, down -79.53% from previous quarter.
SMS Lifesciences India Limited reported a quarterly operating expenses of 199.3 Million INR for 2023 Q2, up 7.98% from previous quarter.

Annual Operating Expenses Chart of SMS Lifesciences India Limited (2023 - 2015)

Historical Annual Operating Expenses of SMS Lifesciences India Limited (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	602.96 Million INR	-75.89%
2022	695.93 Million INR	10.09%
2021	632.15 Million INR	32.17%
2020	478.27 Million INR	17.02%
2019	408.69 Million INR	6.62%
2018	383.33 Million INR	33.03%
2017	288.15 Million INR	-53.0%
2016	613.05 Million INR	3313706.84%
2015	18.5 Thousand INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	22.31 Million INR	148.8%
2023 Q3	40.78 Million INR	-79.53%
2023 Q2	199.3 Million INR	7.98%
2023 Q1	184.57 Million INR	-4.11%
2023 Q4	57.79 Million INR	41.69%
2023 FY	167.82 Million INR	-75.89%
2022 Q2	162.28 Million INR	-1.67%
2022 FY	695.93 Million INR	10.09%
2022 Q4	192.47 Million INR	6.53%
2022 Q1	165.05 Million INR	13.9%
2022 Q3	180.67 Million INR	11.33%
2021 Q4	144.91 Million INR	-18.02%
2021 Q3	176.76 Million INR	2.88%
2021 Q1	142.87 Million INR	40.16%
2021 FY	632.15 Million INR	32.17%
2021 Q2	171.81 Million INR	20.26%
2020 Q1	114.36 Million INR	52.49%
2020 FY	478.27 Million INR	17.02%
2020 Q4	101.93 Million INR	-20.3%
2020 Q3	127.9 Million INR	-7.64%
2020 Q2	138.48 Million INR	21.09%
2019 Q2	123.61 Million INR	26.35%
2019 FY	408.69 Million INR	6.62%
2019 Q4	74.99 Million INR	-27.36%
2019 Q3	103.24 Million INR	-16.48%
2019 Q1	97.83 Million INR	1.75%
2018 Q3	100.21 Million INR	9.53%
2018 FY	383.33 Million INR	33.03%
2018 Q4	96.14 Million INR	-4.06%
2018 Q1	95.71 Million INR	4.27%
2018 Q2	91.49 Million INR	-4.41%
2017 FY	288.15 Million INR	-53.0%
2017 Q4	91.79 Million INR	-51.12%
2017 Q1	216.6 Million INR	134.36%
2017 Q2	174.53 Million INR	-19.42%
2017 Q3	187.79 Million INR	7.59%
2016 Q1	203.14 Million INR	0.0%
2016 Q2	193.44 Million INR	-4.77%
2016 FY	613.05 Million INR	3313706.84%
2016 Q3	225.76 Million INR	16.7%
2016 Q4	92.42 Million INR	-59.06%
2015 FY	18.5 Thousand INR	0.0%

Peer Operating Expenses Comparison of SMS Lifesciences India Limited

Name	Operating Expenses	Operating Expenses Difference
Biocon Limited	40.9 Billion INR	98.526%
Blue Jet Healthcare Limited	531.85 Million INR	-13.372%
Concord Biotech Limited	1.45 Billion INR	58.692%
Dishman Carbogen Amcis Limited	5.14 Billion INR	88.286%
Jubilant Ingrevia Limited	6.67 Billion INR	90.96%
Lyka Labs Limited	599.4 Million INR	-0.594%
Panacea Biotec Limited	1.99 Billion INR	69.782%
Piramal Pharma Limited	19.91 Billion INR	96.972%
Supriya Lifescience Limited	1.08 Billion INR	44.177%
Syngene International Limited	5.99 Billion INR	89.942%
TAKE Solutions Limited	396.91 Million INR	-51.915%
Zota Health Care Limited	457.83 Million INR	-31.7%